ArticleCancer immunology, immunotherapy : CII2020

Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes.

Kenichiro Yahiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.